Skip to main content
OpenTrials

Clinical trial condition

Minimal Change Disease

Explore clinical trials studying Minimal Change Disease. Study availability and eligibility vary by location and protocol.

17 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Minimal Change Disease trial results

Completed

Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease

NCT04009668

Conditions
FSGS, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • The University of Michigan Ann Arbor, Michigan, United States
  • New York University New York, United States
  • Levine Children's Hospital/Atrium Health Charlotte, North Carolina, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
View Trial Details
Completed

Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

NCT02592798

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +11 more
Locations
  • The University Of Alabama At Birmingham Birmingham, Alabama, United States
  • University of Alabama-Birmingham-Parent Account Birmingham, Alabama, United States
  • Los Angeles Biomedical Research Institute Torrance, California, United States
  • University Of Colorado Denver Aurora, Colorado, United States
View all 27 locations
View Trial Details

Related conditions